Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eng-King Tan

Showing results (201-210 of 564) with videos related to

Pageof 57
Sort By:
Translational Neurodegeneration|September 19, 2017
Mild cognitive impairment in Parkinson's disease: a distinct clinical entity?Ming-Ching Wen, Ling Ling Chan, Louis C S Tan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 28, 2016
Large 3-Mb deletions at 22q11.2 locus in Parkinson's disease and schizophreniaJia Nee Foo, Jimmy Lee, Louis C Tan, et al.
Frontiers in Psychiatry|July 4, 2024
Solving the gender paradox in adolescent suicide: challenges and directionsAaron Shengting Mai, Yi-Min Wan, Brendan Jen-Wei Tan, et al.
Journal of Clinical Medicine|January 23, 2024
Association between Type 1 Diabetes Mellitus and Parkinson's Disease: A Mendelian Randomization StudyAaron Shengting Mai, Brendan Jen-Wei Tan, Qiao-Yang Sun, et al.
Ageing Research Reviews|May 16, 2024
Reelin links Apolipoprotein E4, Tau, and Amyloid-β in Alzheimer's diseaseLing Xiao Yi, Li Zeng, Qing Wang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 21, 2025
Binding domains of α-synuclein receptors with monomeric/oligomeric α-synuclein: Implications for Parkinson's diseaseRosalie Elvira, Jia Sheng Guan, Yuguang Mu, et al.
Frontiers in Neuroscience|November 12, 2020
Current Status of Stem Cell-Derived Therapies for Parkinson's Disease: From Cell Assessment and Imaging Modalities to Clinical TrialsSe Eun Jang, Lifeng Qiu, Ling Ling Chan, et al.
Aging|March 5, 2022
Parkinson's disease and cancer: a systematic review and meta-analysis on the influence of lifestyle habits, genetic variants, and genderJoon Yan Selene Lee, Jing Han Ng, Seyed Ehsan Saffari, et al.
Ageing Research Reviews|June 24, 2024
Interaction between caffeine consumption & genetic susceptibility in Parkinson's disease: A systematic reviewYujuan Yang, Zhi Dong Zhou, Lingxiao Yi, et al.
Pharmacogenetics and Genomics|August 14, 2008
The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complicationsMonika Bialecka, Mateusz Kurzawski, Gabriela Klodowska-Duda, et al.
Pageof 57

Showing results (201-210 of 564) with videos related to

Sort By:
Pageof 57
Translational Neurodegeneration|September 19, 2017
Mild cognitive impairment in Parkinson's disease: a distinct clinical entity?Ming-Ching Wen, Ling Ling Chan, Louis C S Tan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 28, 2016
Large 3-Mb deletions at 22q11.2 locus in Parkinson's disease and schizophreniaJia Nee Foo, Jimmy Lee, Louis C Tan, et al.
Frontiers in Psychiatry|July 4, 2024
Solving the gender paradox in adolescent suicide: challenges and directionsAaron Shengting Mai, Yi-Min Wan, Brendan Jen-Wei Tan, et al.
Journal of Clinical Medicine|January 23, 2024
Association between Type 1 Diabetes Mellitus and Parkinson's Disease: A Mendelian Randomization StudyAaron Shengting Mai, Brendan Jen-Wei Tan, Qiao-Yang Sun, et al.
Ageing Research Reviews|May 16, 2024
Reelin links Apolipoprotein E4, Tau, and Amyloid-β in Alzheimer's diseaseLing Xiao Yi, Li Zeng, Qing Wang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 21, 2025
Binding domains of α-synuclein receptors with monomeric/oligomeric α-synuclein: Implications for Parkinson's diseaseRosalie Elvira, Jia Sheng Guan, Yuguang Mu, et al.
Frontiers in Neuroscience|November 12, 2020
Current Status of Stem Cell-Derived Therapies for Parkinson's Disease: From Cell Assessment and Imaging Modalities to Clinical TrialsSe Eun Jang, Lifeng Qiu, Ling Ling Chan, et al.
Aging|March 5, 2022
Parkinson's disease and cancer: a systematic review and meta-analysis on the influence of lifestyle habits, genetic variants, and genderJoon Yan Selene Lee, Jing Han Ng, Seyed Ehsan Saffari, et al.
Ageing Research Reviews|June 24, 2024
Interaction between caffeine consumption & genetic susceptibility in Parkinson's disease: A systematic reviewYujuan Yang, Zhi Dong Zhou, Lingxiao Yi, et al.
Pharmacogenetics and Genomics|August 14, 2008
The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complicationsMonika Bialecka, Mateusz Kurzawski, Gabriela Klodowska-Duda, et al.
Pageof 57